How do Leukotriene Modifiers, like Montelukast, work to prevent asthma symptoms?
Answer
By blocking the action of leukotrienes
Leukotriene Modifiers constitute an important non-steroidal group of medications used to prevent asthma symptoms, often prescribed for patients who cannot tolerate steroids or as an adjunct therapy. Their mechanism of action involves specifically targeting leukotrienes, which are endogenous chemical mediators released by the body that play a significant role in promoting inflammation, mucus production, and airway constriction in asthma. By blocking the effects of these leukotrienes, these medications help dampen the inflammatory response. Montelukast, marketed as Singulair, is the most widely recognized agent in this tablet-form group.
Related Questions
What is the primary function of preventers or controllers in asthma management?Which medication class forms the cornerstone of long-term asthma control?For combination inhalers, why must LABAs be paired with a corticosteroid?Which brand name corresponds to the ICS medication Ciclesonide?What component is added to an ICS and LABA to create triple therapy preventers?How do Leukotriene Modifiers, like Montelukast, work to prevent asthma symptoms?Which combination inhaler is approved for the Single Maintenance And Reliever Therapy (SMART) protocol?What specific driver of inflammation does Omalizumab (Xolair) primarily target?Why might a patient prefer a dry powder device like Ellipta over an Advair MDI requiring a spacer?What did one review state about the strength of a particular Fluticasone HFA formulation?